Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL4893301

Cc1ccc(N)cc1-c1nccc(-c2ccccn2)n1.N

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.44
RAB9A P51151 4/20 0.44
KDM4E B2RXH2 7/20 0.42
L3MBTL1 Q9Y468 5/20 0.42
SMN1; SMN2 Q16637 5/20 0.42
TP53 P04637 3/20 0.42
LMNA P02545 3/20 0.42
ALOX15 P16050 2/20 0.42
CCR1 P32246 2/20 0.42
CCR5 P51681 2/20 0.42
CCR8 P51685 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
ALPL P05186 1/20 0.42
HSP90AA1 P07900 1/20 0.42
ALPI P09923 1/20 0.42
ALPG P10696 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
PKM P14618 3/20 0.42
GAA P10253 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7468150 0.84 NPC1 (0.48) NPC1RAB9AKDM4EL3MBTL1SMN1; SMN2
SCHEMBL25393432 0.82 PLA2G7 (0.50) NPC1RAB9AKDM4EL3MBTL1SMN1; SMN2
SCHEMBL25391936 0.80 PLA2G7 (0.50) NPC1RAB9AKDM4ESMN1; SMN2TP53
Ammonia Solution, Strong SCHEMBL4903577 0.79 ABL1 (0.45) NPC1RAB9AKDM4EHSP90AA1PLA2G7
Ammonia Solution, Strong SCHEMBL2693849 0.77 ABL1 (0.62) HSP90AA1MEN1
Hydrochloric Acid SCHEMBL5531500 0.76 ABL1 (0.61) HSP90AA1MEN1
Pyridine SCHEMBL28228170 0.76 PLA2G7 (0.44) NPC1RAB9AKDM4ESMN1; SMN2TP53
SCHEMBL22206280 0.76 ABL1 (0.63) HSP90AA1CYP3A4MEN1
SCHEMBL4893292 0.75 ABL1 (0.65) SYK
SCHEMBL17306381 0.72 KDM4E (0.47) NPC1RAB9AKDM4EL3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080187575-A1 Pyrimidine Derivatives VICHEM CHEMIE KFT (HU) 2008-08-07 US disclosed
EP-1786781-A2 PYRIMIDINE DERIVATIVES GPC Biotech AG (DE) 2007-05-23 EP disclosed
WO-2006021458-A2 PYRIMIDINE DERIVATIVES GPC BIOTECH AG (DE) 2006-03-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080187575-A1 Pyrimidine Derivatives TYMP, TDP1, PNP NPC1 1001/4885RAB9A 4307/4885KDM4E 2352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.